Literature DB >> 29386262

Evaluation of the Accelerate Pheno System: Results from Two Academic Medical Centers.

Joseph D Lutgring1,2, Cassiana Bittencourt3,4, Erin McElvania TeKippe4,5, Dominick Cavuoti4, Rita Hollaway4, Eileen M Burd2.   

Abstract

Rapid diagnostic tests are needed to improve patient care and to combat the problem of antimicrobial resistance. The Accelerate Pheno system (Accelerate Diagnostics, Tucson, AZ) is a new diagnostic device that can provide rapid bacterial identification and antimicrobial susceptibility test (AST) results directly from a positive blood culture. The device was compared to the standard of care at two academic medical centers. There were 298 blood cultures included in the study, and the Accelerate Pheno system provided a definitive identification result in 218 instances (73.2%). The Accelerate Pheno system provided a definitive and correct result for 173 runs (58.1%). The Accelerate Pheno system demonstrated an overall sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 94.7%, 98.9%, 83.7%, and 99.7%, respectively. An AST result was available for analysis in 146 instances. The overall category agreement was 94.1% with 12 very major errors, 5 major errors, and 55 minor errors. After a discrepancy analysis, there were 5 very major errors and 4 major errors. The Accelerate Pheno system provided an identification result in 1.4 h and an AST result in 6.6 h; the identification and AST results were 41.5 h and 48.4 h faster than those with the standard of care, respectively. This study demonstrated that the Accelerate Pheno system is able to provide fast and accurate organism identification and AST data. A limitation is the frequency with which cultures required the use of alternative identification and AST methods.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  antimicrobial resistance; antimicrobial susceptibility testing; bacteremia; bloodstream infections; diagnostics; rapid diagnostic testing

Mesh:

Substances:

Year:  2018        PMID: 29386262      PMCID: PMC5869849          DOI: 10.1128/JCM.01672-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Evaluation of the Accelerate Pheno System for Fast Identification and Antimicrobial Susceptibility Testing from Positive Blood Cultures in Bloodstream Infections Caused by Gram-Negative Pathogens.

Authors:  Matthias Marschal; Johanna Bachmaier; Ingo Autenrieth; Philipp Oberhettinger; Matthias Willmann; Silke Peter
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

2.  Identification of blood culture isolates directly from positive blood cultures by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry and a commercial extraction system: analysis of performance, cost, and turnaround time.

Authors:  Philippe R S Lagacé-Wiens; Heather J Adam; James A Karlowsky; Kimberly A Nichol; Paulette F Pang; Jodi Guenther; Amanda A Webb; Crystal Miller; Michelle J Alfa
Journal:  J Clin Microbiol       Date:  2012-08-08       Impact factor: 5.948

3.  Individualized Approaches Are Needed for Optimized Blood Cultures.

Authors:  Ritu Banerjee; Volkan Özenci; Robin Patel
Journal:  Clin Infect Dis       Date:  2016-08-23       Impact factor: 9.079

4.  Executive Summary: Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.

Authors:  Tamar F Barlam; Sara E Cosgrove; Lilian M Abbo; Conan MacDougall; Audrey N Schuetz; Edward J Septimus; Arjun Srinivasan; Timothy H Dellit; Yngve T Falck-Ytter; Neil O Fishman; Cindy W Hamilton; Timothy C Jenkins; Pamela A Lipsett; Preeti N Malani; Larissa S May; Gregory J Moran; Melinda M Neuhauser; Jason G Newland; Christopher A Ohl; Matthew H Samore; Susan K Seo; Kavita K Trivedi
Journal:  Clin Infect Dis       Date:  2016-05-15       Impact factor: 9.079

5.  Prospective intervention study with a microarray-based, multiplexed, automated molecular diagnosis instrument (Verigene system) for the rapid diagnosis of bloodstream infections, and its impact on the clinical outcomes.

Authors:  Hiromichi Suzuki; Shigemi Hitomi; Yuji Yaguchi; Kiyoko Tamai; Atsuo Ueda; Kazuhiro Kamata; Yasuharu Tokuda; Hiroshi Koganemaru; Yoko Kurihara; Hiroichi Ishikawa; Hideji Yanagisawa; Katsunori Yanagihara
Journal:  J Infect Chemother       Date:  2015-10-23       Impact factor: 2.211

6.  Evaluation of rapid phenotypic identification and antimicrobial susceptibility testing in a pediatric oncology center.

Authors:  J N Brazelton de Cárdenas; Y Su; A Rodriguez; C Hewitt; L Tang; C D Garner; R T Hayden
Journal:  Diagn Microbiol Infect Dis       Date:  2017-06-23       Impact factor: 2.803

Review 7.  Hospital-acquired infections due to gram-negative bacteria.

Authors:  Anton Y Peleg; David C Hooper
Journal:  N Engl J Med       Date:  2010-05-13       Impact factor: 91.245

Review 8.  Septic shock.

Authors:  Djillali Annane; Eric Bellissant; Jean-Marc Cavaillon
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

9.  Clinical Impact of Laboratory Implementation of Verigene BC-GN Microarray-Based Assay for Detection of Gram-Negative Bacteria in Positive Blood Cultures.

Authors:  Tamar Walker; Sandrea Dumadag; Christine Jiyoun Lee; Seung Heon Lee; Jeffrey M Bender; Jennifer Cupo Abbott; Rosemary C She
Journal:  J Clin Microbiol       Date:  2016-04-20       Impact factor: 5.948

10.  Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel.

Authors:  Joe Pardo; Kenneth P Klinker; Samuel J Borgert; Brittany M Butler; Patricia G Giglio; Kenneth H Rand
Journal:  Diagn Microbiol Infect Dis       Date:  2015-11-11       Impact factor: 2.803

View more
  22 in total

1.  Performance evaluation of Alfred60AST rapid susceptibility testing directly from positive blood cultures in the routine laboratory workflow.

Authors:  Paraskevi Mantzana; Fotini Netsika; Maria Arhonti; Georgios Meletis; Eleni Kandilioti; Maria Kiriakopoulou; Georgia Kagkalou; Olga Vasilaki; Areti Tychala; Efthymia Protonotariou; Lemonia Skoura
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-02-17       Impact factor: 3.267

2.  Evaluation of a Rapid System for Antimicrobial Identification and Antimicrobial Susceptibility Testing in Pediatric Bloodstream Infections.

Authors:  Eric Ward; Kevin Weller; Jacquelyn Gomez; Kiana Roman; Ana María Cárdenas
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

3.  Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections.

Authors:  Ghislaine Descours; Laurent Desmurs; Thi Lam Thuy Hoang; Marine Ibranosyan; Maud Baume; Anne-Gaëlle Ranc; Christine Fuhrmann; Olivier Dauwalder; Waël Salka; François Vandenesch
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-28       Impact factor: 3.267

Review 4.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

5.  Evaluation of EUCAST rapid antimicrobial susceptibility testing (RAST) directly from blood culture bottles.

Authors:  Ying Tong Soo; Siti Nur Mahirah Bte Waled; Sally Ng; Ying Hua Peh; Ka Lip Chew
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-01-18       Impact factor: 3.267

6.  Updates on Rapid Diagnostic Tests in Infectious Diseases.

Authors:  Masako Mizusawa
Journal:  Mo Med       Date:  2020 Jul-Aug

Review 7.  Sequencing-based methods and resources to study antimicrobial resistance.

Authors:  Manish Boolchandani; Alaric W D'Souza; Gautam Dantas
Journal:  Nat Rev Genet       Date:  2019-06       Impact factor: 53.242

8.  Exiguobacterium sp. is endowed with antibiotic properties against Gram positive and negative bacteria.

Authors:  Nicole T Cavanaugh; Anutthaman Parthasarathy; Narayan H Wong; KayLee K Steiner; Jonathan Chu; Joseph Adjei; André O Hudson
Journal:  BMC Res Notes       Date:  2021-06-08

Review 9.  New Microbiological Techniques for the Diagnosis of Bacterial Infections and Sepsis in ICU Including Point of Care.

Authors:  Anna Maria Peri; Adam Stewart; Anna Hume; Adam Irwin; Patrick N A Harris
Journal:  Curr Infect Dis Rep       Date:  2021-06-16       Impact factor: 3.725

10.  Bloodstream infections in critically ill patients: an expert statement.

Authors:  Jean-François Timsit; Etienne Ruppé; François Barbier; Alexis Tabah; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2020-02-11       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.